Interim outcomes of dorsal skin graft bulbar urethroplasty

The Journal of Urology
Guido BarbagliDamiano Turini

Abstract

We update our interim results of bulbar urethroplasty using a skin graft placed on the dorsal urethral surface. A total of 45 patients with an average age of 45 years underwent dorsal onlay skin graft urethroplasty between January 1994 and December 2000. Of the patients 23 had undergone an average of 2.6 prior endoscopic procedures (range 1 to 14). Preoperative evaluation include clinical history, physical examination, retrograde and voiding urethrography, and ultrasonography. In all patients the bulbar urethra was opened along its dorsal surface, the graft was sutured, splayed and quilted to the corpora cavernosa, and the urethra was rotated to cover the graft. In all patients was used penile skin as substitution material. Mean graft length was 4.7 cm (range 2.5 to 11). Three weeks after surgery voiding cystourethrography was performed. Average followup was 71 months (range 41 to 110). Clinical outcome was considered a failure when postoperative instrumentation was needed, including dilation. Of 45 cases 33 (73%) were classified as successful and 12 (27%) were failures. The 12 failures were treated with internal urethrotomy (1), end-to-end-anastomosis (1), skin graft urethroplasty (2) and 2-stage urethroplasty (6). Six of the ...Continue Reading

References

Jan 1, 1996·The Journal of Urology·G BarbagliE Palminteri
Feb 18, 1999·The Journal of Urology·C E Iselin, G D Webster
May 24, 2001·The Journal of Urology·G BarbagliD Turini
Dec 18, 2001·The Journal of Urology·Enzo PalminteriGuido Barbagli
Jun 11, 2003·The Journal of Urology·D E AndrichA R Mundy
Aug 13, 2003·The Journal of Urology·Thomas M KesslerMargit Fisch
Aug 22, 2003·BJU International·G BarbagliG Guazzoni

❮ Previous
Next ❯

Citations

May 10, 2013·Der Urologe. Ausg. A·R Mayr, A Pycha
Feb 20, 2007·International Urology and Nephrology·Demetrios RadopoulosIoannis Vasilakakis
Dec 19, 2013·Nature Reviews. Urology·Lindsay A HampsonBenjamin N Breyer
Oct 1, 2007·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Shivadeo S BapatAshish A Bhave
Jun 20, 2012·Actas urologicas españolas·J C RegueiroM J Requena
Feb 23, 2010·Journal of Pediatric Urology·Christian SchwentnerChristian Radmayr
Aug 22, 2008·European Urology·Daniela E Andrich, Anthony R Mundy
Aug 31, 2007·European Urology·Guido BarbagliMassimo Lazzeri
Jun 15, 2007·The Journal of Urology·Michael R MarkiewiczSung-Kiang Chuang
Jan 15, 2008·BJU International·Orietta DalpiazChristian Schwentner
Aug 15, 2006·Urology·Stefan HauserStefan C Müller
Jun 30, 2006·European Urology·Guido BarbagliGiampaolo Bianchi
Jul 4, 2006·The Journal of Urology·Guido BarbagliMassimo Lazzeri
Feb 19, 2014·The Journal of Urology·Guido BarbagliMassimo Lazzeri
Jul 7, 2012·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Guido BarbagliMassimo Lazzeri
Jan 21, 2017·F1000Research·Maxx A Gallegos, Richard A Santucci
Oct 21, 2006·Current Opinion in Urology·Guido Barbagli, Massimo Lazzeri
Dec 1, 2012·Arab Journal of Urology·Steven J HudakAllen F Morey
Jan 1, 2014·International Scholarly Research Notices·Kamyar Tavakkoli Tabassi, Alireza Ghoreifi
Sep 5, 2007·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Guido Barbagli, Massimo Lazzeri
May 28, 2020·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Cooper R BensonSteven B Brandes
Apr 21, 2021·European Urology·Rachel BarrattUNKNOWN European Association of Urology Urethral Strictures Guidelines Panel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.